13F-HR filed by INTECH INVESTMENT MANAGEMENT LLC
INTECH INVESTMENT MANAGEMENT LLC filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-20, with 2,521 holding rows worth $9,703,530,294.
- Accession
- 0001085146-25-003387
- Filer
- CIK 1086318
- Filed
- 2025-05-20
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 3,106 entries on the cover page, a total value of $9,703,530,294 stated on the cover page (in dollars after the unit check, H1), rows summing to $9,703,530,294 with VALUE read as dollars as filed, 13F file number 028-04211. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerNATIONAL MUTUAL FUNDS MANAGEMENT LTD028-23268
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 32,106 | $20,002 | dollars as filed | |
| ACTINIUM PHARMACEUTICALS | 00507W206 | COM | 12,336 | $19,861 | dollars as filed | |
| FIBROBIOLOGICS INC | 31573L105 | COM SHS | 22,002 | $19,802 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 15,768 | $19,237 | dollars as filed | |
| ModivCare Inc | 60783X104 | Common Stock | 14,367 | $18,893 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 11,809 | $17,832 | dollars as filed | |
| GALECTIN THERAPEUTICS INC | 363225202 | COMMON STOCK | 14,156 | $17,270 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 35,814 | $17,047 | dollars as filed | |
| SOLARMAX TECHNOLOGY INC | 83419H103 | COM SHS | 13,967 | $16,760 | dollars as filed | |
| TEVOGEN BIO HLDGS INC | 88165K101 | COM | 15,503 | $16,743 | dollars as filed | |
| GENERATION BIO CO | 37148K100 | COM | 37,954 | $15,371 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 44,010 | $13,727 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 57,960 | $13,702 | dollars as filed | |
| OUTLOOK THERAPEUTICS INC | 69012T305 | COM | 10,663 | $13,009 | dollars as filed | |
| IGM BIOSCIENCES INC | 449585108 | COM | 11,069 | $12,729 | dollars as filed | |
| 374WATER INC | 88583P104 | COM | 22,770 | $7,742 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W108 | COM | 15,620 | $6,907 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 19,458 | $5,042 | dollars as filed | |
| SOLO BRANDS INC | 83425V104 | COM CL A | 23,150 | $3,885 | dollars as filed | |
| SOLIDION TECHNOLOGY INC | 834212102 | COM | 17,388 | $2,097 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 16,560 | $2,092 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-25-003387 | this filing | 2025-05-20 | acceptance time not in the bulk data set |